在严重喘中控制喘,以及对可吸入喘剂的职业暴露
Gareth I Walters1,2, Christopher Reilly3, Nicole Le Moual4
1Occupational Lung Disease Service, Birmingham Heartlands Hospital, Birmingham, UK gareth.walters@uhb.nhs.uk.
BMJ open respiratory research
|September 30, 2024
概括
工作场所暴露于吸入性喘剂与严重喘患者的喘控制不佳无关. 许多严重喘患者面临职业暴露,突出需要更好的数据收集.
科学领域:
- 职业健康 职业健康 职业健康
- 肺部病理学 肺部病理学
- 流行病学 流行病学
背景情况:
- 与工作相关的喘影响着相当一部分劳动年龄人口,往往导致不良的健康和就业结果.
- 职业暴露与喘症状之间的联系经常被忽视.
- 严重喘 (SA) 管理可能会受到工作场所环境因素的影响.
研究的目的:
- 调查可吸入的工作场所暴露和严重喘患者的喘控制之间的关联.
- 为了确定职业喘是否与喘控制问题相关,用喘控制问卷7 (ACQ7) 进行测量.
主要方法:
- 一项横截面研究分析了来自伯明翰 (英国) 区域NHS SA服务数据库的504名就业重症喘患者 (16-64岁) 的数据.
- 职业喘特定工作暴露矩阵 (OAsJEM) 评估了对敏感剂,刺激剂和清洁剂的暴露可能性.
- 二进制和多项回归分析探讨了职业暴露和ACQ7分数之间的关联.
主要成果:
- 39%的患者暴露于喘因子,包括呼吸道敏感剂 (30%),气道刺激剂 (38%) 和清洁剂 (29%).
- 在具有可用ACQ7评分 (n=372) 的患者中,只有14%的人获得了足够的喘控制 (ACQ7=0-1.5).
- 在调整了混因素后,在JEM确定的吸入性喘暴露和喘控制水平之间没有发现显著的关联.
结论:
- 工作暴露 通过矩阵确定的工作场所对吸入性喘剂的暴露似乎与严重喘中的喘控制无关.
- 很大一部分严重喘患者 (29-39%) 可能会持续暴露在工作场所的喘因子中.
- 建议在国家喘登记处定期收集全面的职业病史,包括当前的工作和暴露水平,以进行进一步的研究.
相关概念视频
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
241
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
241
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
226
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
226
Asthma-IV: Nursing Management
3.0K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.0K


